Search Results 831-840 of 19317 for Hemoglobin

  1. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  2. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  4. Mayo Clinic Q and A: Understanding and treating fibroelastomas

    DEAR MAYO CLINIC: I am an 83-year-old woman on warfarin because of atrial fibrillation, and I recently was diagnosed with a fibroelastoma.

  5. Continued type 2 diabetes mellitus remission independent of weight loss observed in patients after Roux-en-Y gastric bypass - Mayo Clinic

    Baseline insulin use, higher hemoglobin A1C levels and longer preoperative duration of T2DM were associated with T2DM recurrence, while weight recurrence was ...

  6. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  7. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  8. Myelofibrosis - Symptoms and causes - Mayo Clinic

    Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.

  9. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  10. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...